|
Journal of Neurotrauma
A Preliminary Study of Intravenous Surfactants in Paraplegic Dogs: Polymer Therapy in Canine Clinical SCI
To cite this article:
Peter H. Laverty, Alenka Leskovar, Gert J. Breur, Joan R. Coates, Robert L. Bergman, William R. Widmer, James P. Toombs, Scott Shapiro, Richard B. Borgens.
Journal of Neurotrauma.
December 2004,
21(12): 1767-1777.
doi:10.1089/neu.2004.21.1767.
Peter H. Laverty Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana. Alenka Leskovar Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas. Gert J. Breur Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana. Joan R. Coates Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas. Robert L. Bergman Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas. William R. Widmer Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana. James P. Toombs Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana. Scott Shapiro Department of Neurosurgery, Indiana University Medical Center, Indianapolis, Indiana. Richard B. Borgens, Ph.D.Department of Basic Medical Sciences, Center for Paralysis Research, Purdue University, West Lafayette, Indiana. Department of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, Indiana. Hydrophilic polymers, both surfactants and triblock polymers, are known to seal defects in cell membranes. In previous experiments using laboratory animals, we have exploited this capability using polyethylene glycol (PEG) to repair spinal axons after severe, standardized spinal cord injury (SCI) in guinea pigs. Similar studies were conducted using a related co-polymer Poloxamer 188 (P 188). Here we carried out initial investigations of an intravenous application of PEG or P 188 (3500 Daltons, 30% w/w in saline; 2 mL/kg I.V. and 2 mL/kg body weight or 300 mL P 188 per kg, respectively) to neurologically complete cases of paraplegia in dogs. Our aim was to first determine if this is a clinically safe procedure in cases of severe naturally occurring SCI in dogs. Secondarily, we wanted to obtain preliminary evidence if this therapy could be of clinical benefit when compared to a larger number of similar, but historical, control cases. Strict entry criteria permitted recruitment of only neurologically complete paraplegic dogs into this study. Animals were treated by a combination of conventional and experimental techniques within 72 h of admission for spinal trauma secondary to acute, explosive disk herniation. Outcome measures consisted of measurements of voluntary ambulation, deep and superficial pain perception, conscious proprioception in hindlimbs, and evoked potentials (somatosensory evoked potentials [SSEP]). We determined that polymer injection is a safe adjunct to the conventional management of severe neurological injury in dogs. We did not observe any unacceptable clinical response to polymer injection; there were no deaths, nor any other problem arising from, or associated with, the procedures. Outcome measures over the 6–8-week trial were improved by polymer injection when compared to historical cases. This recovery was unexpectedly rapid compared to these comparator groups. The results of this pilot trial provides evidence consistent with the notion that the injection of inorganic polymers in acute neurotrauma may be a simple and useful intervention during the acute phase of the injury.  This paper was cited by:INTRAVENOUS POLYETHYLENE GLYCOL SUCCESSFULLY TREATS SEVERE ACCELERATION-INDUCED BRAIN INJURY IN RATS AS ASSESSED BY MAGNETIC RESONANCE IMAGING Philip Smucker, S. K. Hekmatyar, Navin Bansal, Richard B. Rodgers, Scott A. Shapiro, Richard B. Borgens Neurosurgery. Jun 2009, Vol. 64, No. 5: 984-990 CrossRef Neural Precursors from Canine Skin: A New Direction for Testing Autologous Cell Replacement in the Brain Michael J. Valenzuela, Sophia K. Dean, Perminder Sachdev, Bernard E. Tuch, Kuldip S. Sidhu Stem Cells and Development. Dec 2008, Vol. 17, No. 6: 1087-1094 Abstract | Full Text PDF | Reprints & PermissionsRepairing the Damaged Spinal Cord and Brain with Nanomedicine Youngnam Cho, Riyi Shi, Richard Borgens, Albena Ivanisevic Small. Nov 2008, Vol. 4, No. 10: 1676-1681 CrossRef Neural tissue engineering of the CNS using hydrogels David R. Nisbet, Kylie E. Crompton, Malcolm K. Horne, David I. Finkelstein, John S. Forsythe Journal of Biomedical Materials Research Part B: Applied Biomaterials. Nov 2008, Vol. 87B, No. 1: 251-263 CrossRef Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death Youngnam Cho, Riyi Shi, Richard B Borgens, Albena Ivanisevic Nanomedicine. Sep 2008, Vol. 3, No. 4: 507-519 CrossRef Emerging drugs for spinal cord injury Darryl C Baptiste, Michael G Fehlings Expert Opinion on Emerging Drugs. Apr 2008, Vol. 13, No. 1: 63-80 CrossRef Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat David S. Ditor, Sunil M. John, Josee Roy, Jeffrey C. Marx, Colin Kittmer, Lynne C. Weaver Journal of Neuroscience Research. Jun 2007, Vol. 85, No. 7: 1458-1467 CrossRef Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy N D Jeffery, P M Smith, A Lakatos, C Ibanez, D Ito, R J M Franklin Spinal Cord. Nov 2006, Vol. 44, No. 10: 584-593 CrossRef Polyethylene glycol treatment after traumatic brain injury reduces β-amyloid precursor protein accumulation in degenerating axons Andrew O. Koob, Richard B. Borgens Journal of Neuroscience Research. Jul 2006, Vol. 83, No. 8: 1558-1563 CrossRef Bioengineered Strategies for Spinal Cord Repair Hiroshi Nomura, Charles H. Tator, Molly S. Shoichet Journal of Neurotrauma. Apr 2006, Vol. 23, No. 3-4: 496-507 Abstract | Full Text PDF | Reprints & PermissionsCancer researchers usher in dog days of medicine George S Mack Nature Medicine. Nov 2005, Vol. 11, No. 10: 1018-1018 CrossRef Intravenous Polyethylene Glycol Inhibits the Loss of Cerebral Cells after Brain Injury Andrew O. Koob, Bradley S. Duerstock, Charles F. Babbs, Yinlong Sun, Richard B. Borgens Journal of Neurotrauma. Oct 2005, Vol. 22, No. 10: 1092-1111 Abstract | Full Text PDF | Reprints & Permissions
|
|